SCHEMBL23279531

SCHEMBL23279531

C=C/C=C(\C(C)OC(=O)[C@H](CC(C)(C)F)N(C)C(=O)OC(C)(C)C)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19088621 0.79 AAK1 (0.34) —
SCHEMBL26034208 0.77 AAK1 (0.33) —
SCHEMBL24093734 0.76 AAK1 (0.33) —
SCHEMBL18248195 0.74 AAK1 (0.36) —
SCHEMBL18248194 0.74 AAK1 (0.36) —
SCHEMBL20166246 0.73 NFKB1 (0.35) —
SCHEMBL24093690 0.72 MMP13 (0.38) —
SCHEMBL18256297 0.72 MMP13 (0.38) —
SCHEMBL18248065 0.72 MMP13 (0.38) —
SCHEMBL18248003 0.71 MMP13 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3298027-B1 ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC (US) 2021-04-28 — — EP disclosed
Send feedback